Updated NORML Report Reviews Nearly 200 Studies on the Therapeutic Use of Cannabis

NORML has recently posted online the fourth edition of its popular and comprehensive booklet, "Emerging Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature." Updated and revised for 2011, this report reviews approximately 200 newly published scientific studies assessing the safety and efficacy of marijuana and its compounds in the treatment and management of nineteen clinical indications: Alzheimer’s disease, Amyotrophic Lateral Sclerosis (ALS), chronic pain, diabetes mellitus, dystonia, fibromyalgia, gastrointestinal disorders, gliomas and other cancers, hepatitis C, human immunodeficiency virus (HIV), hypertension, incontinence, methicillin-resistant Staphyloccus aureus (MRSA), multiple sclerosis, osteoporosis, pruritus, rheumatoid arthritis, sleep apnea, and Tourette’s syndrome.